Subarachnoid Hemorrhage Surgical Devices Market Outlook:
Subarachnoid Hemorrhage Surgical Devices Market size was valued at USD 1.5 billion in 2025 and is projected to reach USD 2.9 billion by the end of 2035, rising at a CAGR of 5.3% during the forecast period, i.e., 2026-2035. In 2026, the industry size of subarachnoid hemorrhage surgical devices is estimated at USD 1.6 billion.
The rising occurrence of cerebral aneurysms and continued advancements in minimally invasive neurointerventional techniques are the key factors behind the robust growth of the subarachnoid hemorrhage (SAH) surgical devices market. Testifying to this, the NLM in May 2023 revealed that hemorrhagic stroke causes 10% to 20% of strokes on a yearly basis, wherein the incidence is 12% to 15% of cases per 1,00,000 per year, especially in developing countries, hence positively influencing market growth.
Furthermore, the aspect of the pricing of surgical devices for subarachnoid hemorrhage treatment is readily influenced by payers, which include government healthcare programs, private insurers, and hospital procurement policies. In this context, the September 2022 cost-utility analysis published by NIH found that endovascular coiling is more cost-effective than neurosurgical clipping for treating aneurysmal subarachnoid haemorrhage in the UK, wherein both NICEs, EC demonstrated both monetary and health net benefits.
